Search - tctmd.com

Displaying 141 - 160 of 575

Sort: Relevancy | Date

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Daily News

ACC/AHA Release Updated Aortic Disease Guideline

Todd Neale

November 02, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Conference News EACTS 2022

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Michael O'Riordan

October 12, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

News Conference News ESC 2022

ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death

Todd Neale

September 02, 2022

News Daily News

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

Yael L. Maxwell

September 02, 2022

News Conference News ESC 2022

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Shelley Wood

September 01, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

US, European Hypertension Guidelines: More Alike Than Different

Caitlin E. Cox

August 17, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Advertisement

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

ACC/AHA Release Updated Aortic Disease Guideline

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

SCAAR Registry Delves Into Left Main Revascularization Outcomes

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Care Around Noncardiac Surgery: New ESC Guidelines

Routine Functional Testing Unnecessary After Stenting: POST-PCI

ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

What’s Going to Be Hot at ESC 2022?

US, European Hypertension Guidelines: More Alike Than Different

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content